FDA: More Blood Pressure Drugs May Have Shortages After Recalls

by Reuters   Additional shortages of blood pressure drugs in the United States are possible following recent recalls related to traces of a probable carcinogen found in some versions a particular class of hypertension medicines, the U.S. Food and Drug Administration said Friday. The drugs, including valsartan, belong to a…

Read More